Intra-Cellular Therapies, Inc. (ITCI)
NASDAQ: ITCI · IEX Real-Time Price · USD
74.86
-0.08 (-0.11%)
At close: Jul 19, 2024, 4:00 PM
75.32
+0.46 (0.61%)
Pre-market: Jul 22, 2024, 5:44 AM EDT
Intra-Cellular Therapies Employees
Intra-Cellular Therapies had 610 employees as of December 31, 2023. The number of employees increased by 49 or 8.73% compared to the previous year.
Employees
610
Change (1Y)
49
Growth (1Y)
8.73%
Revenue / Employee
$842,508
Profits / Employee
-$181,751
Market Cap
7.90B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 610 | 49 | 8.73% |
Dec 31, 2022 | 561 | 49 | 9.57% |
Dec 31, 2021 | 512 | 129 | 33.68% |
Dec 31, 2020 | 383 | 53 | 16.06% |
Dec 31, 2019 | 330 | 257 | 352.05% |
Dec 31, 2018 | 73 | 24 | 48.98% |
Dec 31, 2017 | 49 | 7 | 16.67% |
Dec 31, 2016 | 42 | 3 | 7.69% |
Dec 31, 2015 | 39 | 13 | 50.00% |
Dec 31, 2014 | 26 | 4 | 18.18% |
Mar 31, 2013 | 22 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
The Ensign Group | 35,300 |
Chemed | 15,087 |
Bio-Rad Laboratories | 8,030 |
Bio-Rad Laboratories | 8,030 |
Penumbra | 4,200 |
Roivant Sciences | 908 |
Ascendis Pharma | 879 |
Lantheus Holdings | 834 |
ITCI News
- 4 weeks ago - Intra-Cellular Therapies' Highlights Successful Data From Second Depression Study - Benzinga
- 4 weeks ago - Intra-Cellular Therapies Announces Positive Topline Results in Second Phase 3 Trial Evaluating Lumateperone as Adjunctive Therapy in Patients with Major Depressive Disorder - GlobeNewsWire
- 6 weeks ago - Intra-Cellular Therapies to Present at the 45th Annual Goldman Sachs Global Healthcare Conference - GlobeNewsWire
- 7 weeks ago - Intra-Cellular Therapies to Present at the Jefferies Global Healthcare Conference - GlobeNewsWire
- 2 months ago - Intra-Cellular Therapies Highlights Data Presentations at the American Society of Clinical Psychopharmacology Annual Meeting - GlobeNewsWire
- 2 months ago - Intra-Cellular Therapies Reports First Quarter 2024 Financial Results - GlobeNewsWire
- 2 months ago - Intra-Cellular Therapies to Host First Quarter 2024 Financial Results Conference Call and Webcast - GlobeNewsWire
- 3 months ago - Intra-Cellular Therapies Announces Closing of $575 Million Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares - GlobeNewsWire